Wellstar ENT & Allergy Care

We are excited to share the results of an insightful evaluation of Wellstar’s Community Transformation Program (CTP), completed by our partner, WE Public Health. This evaluation marks an important milestone as we continue to drive meaningful community-level change through the work of the Wellstar Center for Health Equity (WCHE) and our dedicated grantees.

Each year, CTP invites local organizations in Metro Atlanta to request support for a new or existing tech-based initiative that addresses health disparities in our communities. Nineteen organizations have received grants through the program, including eight in the most recent group. To measure the impact of this program and study how Wellstar’s support has helped these organizations further their reach, we partnered with WE Public Health for an evaluation of CTP.

About WE Public Health

WE Public Health is a consulting firm focused on advancing health equity through strategic partnerships, capacity building and community engagement. Their work empowers organizations and communities to address health and social challenges with a specific focus on justice and equity.

Why Wellstar chose WE Public Health

WCHE partnered with WE Public Health to develop a comprehensive monitoring and evaluation strategy because we recognized the importance of a thorough evaluation to help understand the impact and sustainability of our CTP. The evaluation reviewed the first three groups of Community Transformation Program (CTP) grantees (2020 to 2023) to assess how effectively they improved access to medical care and social services through technology. Findings guide program improvements, support communication with stakeholders and help achieve industry recognition. 

• Program reach (partners served, demographics and counties)
• Financial investment (technology and total funding)
• Improved access to care and support services
• Program sustainability post-grant
• Impact on clients and grantee organizations
• Uniqueness of Wellstar’s investment
• Social return on investment

Key evaluation findings and impact

Health equity and social determinants of health

The evaluation highlighted the alignment of the CTP with Wellstar’s commitment to addressing social determinants of health, or factors that can affect a person’s well-being, including access to food, housing and transportation. Our CTP focused on six key areas identified through Wellstar's 2019 Community Health Needs Assessment (CHNA). WCHE launched the CTP in response to a technology equity gap identified in the assessment. The program addresses the need to improve access to medical care and social support services for vulnerable, marginalized and underserved communities.

Impressive cost avoidance and health outcomes

The evaluation also demonstrated that CTP grantees are having a significant impact on health outcomes. While the estimated reach from our program’s services exceeds 13,000 people, of those nearly 2,250 people benefited specifically from either mental and/or physical health interventions. The estimated cost avoidance from emergency department visits for these patients ranged from $225,000 to over $1 million. This not only underscores the financial impact of the program, but also reflects its success in preventing the need for emergency care.

Sustained use of technology solutions

A key aspect of the CTP was its emphasis on integrating technology solutions to enhance health services. According to the evaluation, six out of seven grantee organizations interviewed reported continuing use of the technology solutions funded through the CTP, indicating strong buy-in and long-term benefits. These positive findings reflect the success of the program in providing grantees with the resources and support to test and scale innovative solutions in a low-risk environment.

Positive experiences and strong partnerships

Grantees and partners reported positive experiences working with Wellstar team members, highlighting our emphasis on collaboration, capacity building and fostering strong relationships. The evaluation emphasized the effectiveness of Wellstar's supportive approach, which allowed grantees to explore new solutions while minimizing risks.

Guiding our growth

One of the most valuable outcomes of this evaluation was the expert guidance provided on how to strengthen and scale the program. WE Public Health offered strategic recommendations focused on deepening community partnerships, supporting long-term sustainability and enhancing evaluation practices. These insights will serve as a roadmap as we continue refining the CTP to maximize impact and equity. 

Why this matters

The findings from this evaluation affirm the transformative impact the CTP has had on both the health outcomes of individuals and the broader community. By fostering partnerships, addressing key social determinants of health and investing in sustainable technology solutions, the CTP is helping to create lasting change in the communities we serve.

As we continue to work with WE Public Health, we are excited to build upon these results and expand our efforts to address health inequities across Georgia. The partnership between Wellstar, WE Public Health and our grantees continues to serve as a model for how community-driven programs can drive sustainable improvements in health and well-being.

Learn more about WCHE. 

Screening for prostate cancer is crucial for early detection and to help provide the best possible outcome. It is especially important for Black men to be vigilant about screening, as they are disproportionately impacted by this cancer.

About 1 in 6 Black men will be diagnosed with prostate cancer in their lifetime, compared to 1 in 8 white men, according to a report from the American Cancer Society. Prostate cancer is the second leading cause of cancer death in Black men.

The American Cancer Society recommends that men at an average risk of developing prostate cancer begin screening when they are 50, but Black men should start earlier—at age 45 if they have no family history of prostate cancer, and at age 40 if any of their male relatives have had prostate cancer. Wellstar takes a personalized approach to cancer screenings, with clinicians discussing benefits versus risks of screening and helping patients evaluate their risk.

“Despite many physicians being aware of this and following this practice, Black men continue to be diagnosed with and die from metastatic prostate cancer. This is a trend that desperately needs to be reversed,” said Wellstar Primary Care Physician Dr. Earl Stewart. “We have adequate screening tools that do not even require a digital rectal examination.”

The Prostate-Specific Antigen (PSA) blood test is more accurate than the digital rectal examination in helping to detect prostate cancer, according to Dr. Stewart. Patients should also discuss family history with their relatives. “Patients knowing their family history is so crucial in having those discussions with primary care physicians to determine the best age at which to start screening,” Dr. Stewart said.

Screening for prostate cancer is as simple as making a preventive appointment with your primary care physician, discussing your family history with him or her, and having a PSA blood test. This test may be performed during an annual physical or wellness visit. Shared decision making between physician and patient is important to discuss your risk, your need for testing and next steps to take if your PSA level is elevated and concerning. Knowing your risk can save your life.

“I know many personally who are near and dear to me who had the disease and who unfortunately died from complications of metastatic prostate cancer,” Dr. Stewart said. “I know many more who lived because they had the conversation and dared to move forward with appropriate screening at the appropriate age.”

Learn more about prostate cancer care at Wellstar.